News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Year202520242023 MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Fulltext search Search Vall d’Hebron identifies new potential biomarkers of irritable bowel syndrome 30/10/2025 Vall d’Hebron hosts an event on research into the health benefits of the arts 23/10/2025 Vall d'Hebron highlights the potential of synbiotics to control irritability 22/07/2024 Genetic basis of ADHD and autism spectrum disorder impacts on school performance 31/05/2024 A genetic study indicates that ADHD is associated with lower life expectancy 09/05/2023 COVID-19 increases the risk of developing irritable bowel syndrome in the long term 17/03/2023 A Vall d'Hebron project receives a grant by the European Crohn's and Colitis Organization 06/03/2023 Largest genetic study in ADHD identifies new genome regions associated with the disorder 24/02/2023 Four Vall d’Hebron mental health projects awarded in the 2021 TV3 La Marató charity event 03/11/2022 A study by Dr. Luis G Alcalá, selected for the Young Investigator Forum 01/08/2022 Dr Amanda Rodríguez presents her book 'Siente lo que comes' 05/04/2022 Test of Vall d’Hebron and GoodGut to diagnose irritable bowel syndrome 16/03/2022 New study shows the relationship between insomnia and ADHD improvement 03/03/2022 New report with the collaboration of Vall d’Hebron calls for clearer definition of treatment-resistant depression 15/12/2021 Vall d'Hebron studies the effectiveness of online interventions for cannabis addiction in young people 07/12/2021 Study from Vall d'Hebron determines that the Mediterranean diet increases the colon's microbiota 17/10/2021 Families with transplanted children feel more understood due to the widespread use of prevention measures, such as masks 15/09/2021 Vall d'Hebron demonstrates that the gut microbiota can facilitate the diagnosis of Crohn's disease and ulcerative colitis 21/06/2021 Vall d'Hebron participates in a study that identifies 33 new genetic variants associated with bipolar disorder 16/05/2021 Vall d’Hebron enrolls the first patient in a Phase IIb clinical trial by Oryzon for Borderline Personality Disorder 28/03/2021 Pagination 1 2 Next › Next page Last » Last page